Dana-Farber has launched an extensive research project into cancer genomics.
John Quackenbush, PhD, commented on a study that showed understanding a tumor's genomic profile is more likely to lead to an effective treatment.
Dr. Koen M. A. Dreijerink participated in a study that suggested the MEN1 mutation is also involved in the formation of breast cancer tumors.
The Dana-Farber Mammography Van and the Blum Family Van travel around the Greater Boston area providing cancer screenings.
Tags: BreastCancer, PatientSupport, YawkeyCenter, Prevention, Imaging
Tags: Leukemia, CopingWithCancer
Dr. Sung-Yun Pai led a study that found children with the immune disorder known as “bubble boy disease” who received stem cell transplants within three-and-a-half months of birth had the highest rates of survival.
In a 2013 study conducted by Shoshana Rosenberg, ScD, women younger than 40 with no increased genetic risk and disease in one breast believed that within five years, 10 out of 100 of them would develop it in the other.
Dr. Suzanne George commented on a study showing that undetected tumors in women having hysterectomies are more common than many experts had thought, a conclusion that is fueling calls to limit or eliminate a particular hysterectomy procedure.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: